Exploration of the Correlations Between Interferon-γ in Patient Serum and HEPACAM in Bladder Transitional Cell Carcinoma, and the Interferon-γ Mechanism Inhibiting BIU-87 Proliferation
Authors:
- 20 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 188 (4) , 1346-1353
Abstract
Interferon-γ inhibits cancer cell proliferation and induces re-expression of different tumor suppressor genes. As a candidate, HEPACAM is almost lost in bladder transitional cell carcinoma. To our knowledge whether interferon-γ inhibits BIU-87 proliferation and re-expresses HEPACAM mRNA is still unknown. Thus, we probed the mechanism and examined the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma. Using enzyme-linked immunosorbent assay we measured serum interferon-γ in 27 men and 6 women, and 15 volunteers. Disease was Ta–T1 in 12 patients, T2–T4 in 21, low grade in 25, high grade in 8, primary in 13 and recurrent in 20. A total of 33 cancer and 26 adjacent tissues were examined by immunohistochemistry to detect HEPACAM protein and ensure the position. Under interferon-γ stimulation we detected BIU-87 proliferation by MTT assay. Cell cycles were examined by flow cytometry. HEPACAM mRNA expression was determined by reverse transcription-polymerase chain reaction. Western blot was used to detect p21WAF1. Interferon-γ was remarkably low in patients with bladder transitional cell carcinoma vs volunteers (p HEPACAM mRNA (p 0/G1 and p21WAF1 was concurrently increased in response to interferon-γ (p WAF1 up-regulation to arrest cells at the G0/G1 phase.Keywords
This publication has 18 references indexed in Scilit:
- Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot StudyClinical Cancer Research, 2011
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13Cancer Immunology, Immunotherapy, 2011
- Functional significance of the hepaCAM gene in bladder cancerBMC Cancer, 2010
- HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastasesBMC Veterinary Research, 2010
- Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cellsCarcinogenesis, 2008
- Down-regulation of PHLDA1 gene expression is associated with breast cancer progressionBreast Cancer Research and Treatment, 2007
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Interferon γ Induces the Expression of p21waf-1 and Arrests Macrophage Cell Cycle, Preventing Induction of ApoptosisImmunity, 1999
- Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domainsOncogene, 1997
- Role of Interferon Regulatory Factor-1 in the Induction of Biliary Glycoprotein (Cell CAM-1) by Interferon-γJournal of Biological Chemistry, 1996